Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Kann Inspiration Mining die nächste 1.000 % Chance werden? Das Bohrprogramm startet in wenigen Tagen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40GH4 | ISIN: US75946W4050 | Ticker-Symbol:
NASDAQ
12.05.26 | 21:56
0,148 US-Dollar
0,00 % 0,000
1-Jahres-Chart
RELIANCE GLOBAL GROUP INC Chart 1 Jahr
5-Tage-Chart
RELIANCE GLOBAL GROUP INC 5-Tage-Chart

Aktuelle News zur RELIANCE GLOBAL GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoReliance Global Group reports Q1 results1
DoReliance Global Group, Inc.: Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments178Company Expands Ownership-Driven Investment Model While Maintaining Insurance and InsurTech Operating Foundation Company to Host Conference Call Today at 4:30 PM Eastern Time LAKEWOOD, N.J., May 07...
► Artikel lesen
DoReliance Global Group, Inc. - 10-Q, Quarterly Report-
05.05.Reliance Global Group, Inc.: Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals ...1
04.05.Reliance Global Group, Inc. - 8-K, Current Report-
04.05.Reliance Global Forges Links with LifeSci Global1
RELIANCE GLOBAL GROUP Aktie jetzt für 0€ handeln
04.05.Reliance Global Group, Inc.: Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA's Biotech Division126Transaction Expands EZRA International Group's Biotech Division, LifeSci Global, Into Late-Stage Radiopharmaceutical Imaging Initial Neuroblastoma Opportunity of Approximately $250 Million, with Additional...
► Artikel lesen
28.04.Reliance Global increases Enquantum stake to 29%2
28.04.Reliance Global Group, Inc.: Reliance Global Group Increases Ownership in Enquantum to 29% Following Achievement of Defined Technical and Commercial Milestones4
13.04.Reliance Global launches updated insurtech platform, RELI Exchange 2.02
10.04.Centri: Reliance Global Group to Participate in Centri Capital Conference at Nasdaq MarketSite in New York City on April 14, 2026344Lakewood, New Jersey--(Newsfile Corp. - April 10, 2026) - Reliance Global Group, Inc. (NASDAQ: EZRA) ("we," "us," "our," the "Company" or "Reliance") today announced that Ezra Beyman, Chairman and...
► Artikel lesen
25.03.Reliance Global Group, Inc.: Reliance Global Group Launches RELI Exchange 2.0 to Drive Faster, More Efficient Growth1
19.03.Reliance Global increases Enquantum stake to 12% after milestone2
19.03.Reliance Global erhöht Beteiligung an Enquantum auf 12 % nach Meilenstein1
19.03.Reliance Global Group, Inc.: Reliance Global Group Funds Next Enquantum Milestone, Increasing Ownership and Securing Additional Board Seat1
17.03.Reliance Global Group schließt Vergleiche und ändert Aktienkaufvertrag1
17.03.Reliance Global Group, Inc. - 8-K, Current Report1
12.03.Reliance Global Group reports FY results2
10.03.Earnings Call zu Q4 2025: Reliance Global stellt strategische Weichen neu und setzt auf Technologie2
10.03.Reliance Global Group reports 2025 results, invests in cybersecurity2
Weiter >>
81 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1